Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Mol Cancer Ther. 2018 Feb 7;17(4):858–868. doi: 10.1158/1535-7163.MCT-17-0965

Table 1.

Number of tumor-bearing KP mice assigned to each experimental group

Brookhaven National Laboratory, Upton NY Duke University, Durham NC
Untreated controls 28 Untreated controls 10
Received 10 Gy CIT* 24 Received 20 Gy X-rays 12
 • Followed for growth delay 16     • Anesthetized with ketamineˆ 8
 • Harvested for tissue analysis 7     • Anesthetized with isofluraneƒ 4
  ◦ 4-hours post-treatment 1 Received 25 Gy X-raysƒ 8
  ◦ 24-hours post-treatment 3 Received 30 Gy X-raysƒ 17
  ◦ 48-hours post-treatment 3     • Followed for growth delay 8
    • Harvested for tissue analysis 9
        ◦ 24-hours post-treatment 4
        ◦ 48-hours post-treatment 5
Total 52 Total 47

followed for growth delay;

harvested for tissue analysis;

anesthetized with intraperitoneal ketamine and xylazine;

ƒ

anesthetized with isoflurane;

*

one mouse moved out of treatment portal during CIT and was thus omitted all analyses;

ˆ

two mice treated with 20 Gy X-rays succumbed prior to tumor quintupling and were thus omitted from the quintupling time analysis